Related Experiment Video
Updated: May 12, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
Advances in stem cell therapy against gliomas
M Sarah S Bovenberg1, M Hannah Degeling, Bakhos A Tannous
1Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Department of Neurology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA 02129, USA.
Stem cell therapy offers a promising, tumor-selective approach for treating malignant gliomas, potentially overcoming limitations of current treatments. This method leverages stem cells to target cancer cells and stimulate anti-tumor responses.
Area of Science:
- Neuro-oncology
- Regenerative Medicine
- Cancer Therapy
Background:
- Malignant gliomas are aggressive brain tumors with poor prognoses.
- Current treatments (surgery, radiation, chemotherapy) have limitations due to invasiveness and recurrence.
- Stem cell-based therapy presents a novel, tumor-selective alternative.
Purpose of the Study:
- To review current trends and recent advancements in stem cell therapy for malignant gliomas.
- To explore the potential of various stem cell types in targeting brain tumors.
- To discuss mechanisms of stem cell-mediated anti-tumor effects.
Main Methods:
- Review of experimental and clinical studies on stem cell therapy for gliomas.
- Analysis of stem cell types including neural, mesenchymal, and hematopoietic stem cells.
- Examination of therapeutic strategies utilizing stem cells for targeted delivery.
Main Results:
- Stem cell therapy demonstrates tumor selectivity, sparing healthy brain tissue.
- Stem cells can be engineered to deliver therapeutic agents like prodrugs or oncolytic viruses.
- Potential for long-term antitumor responses through immune system stimulation.
Conclusions:
- Stem cell therapy is a viable and evolving strategy for malignant glioma treatment.
- Further research and clinical trials are essential to optimize this approach.
- This therapy holds promise for improving outcomes in patients with brain tumors.

